144 related articles for article (PubMed ID: 32546520)
1. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.
Jimenez-Vargas NN; Gong J; Wisdom MJ; Jensen DD; Latorre R; Hegron A; Teng S; DiCello JJ; Rajasekhar P; Veldhuis NA; Carbone SE; Yu Y; Lopez-Lopez C; Jaramillo-Polanco J; Canals M; Reed DE; Lomax AE; Schmidt BL; Leong KW; Vanner SJ; Halls ML; Bunnett NW; Poole DP
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15281-15292. PubMed ID: 32546520
[TBL] [Abstract][Full Text] [Related]
2. Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.
Yarwood RE; Imlach WL; Lieu T; Veldhuis NA; Jensen DD; Klein Herenbrink C; Aurelio L; Cai Z; Christie MJ; Poole DP; Porter CJH; McLean P; Hicks GA; Geppetti P; Halls ML; Canals M; Bunnett NW
Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12309-12314. PubMed ID: 29087309
[TBL] [Abstract][Full Text] [Related]
3. Delta opioid receptors on nociceptive sensory neurons mediate peripheral endogenous analgesia in colitis.
Mas-Orea X; Basso L; Blanpied C; Gaveriaux-Ruff C; Cenac N; Dietrich G
J Neuroinflammation; 2022 Jan; 19(1):7. PubMed ID: 34991641
[TBL] [Abstract][Full Text] [Related]
4. A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain.
Ramírez-García PD; Retamal JS; Shenoy P; Imlach W; Sykes M; Truong N; Constandil L; Pelissier T; Nowell CJ; Khor SY; Layani LM; Lumb C; Poole DP; Lieu T; Stewart GD; Mai QN; Jensen DD; Latorre R; Scheff NN; Schmidt BL; Quinn JF; Whittaker MR; Veldhuis NA; Davis TP; Bunnett NW
Nat Nanotechnol; 2019 Dec; 14(12):1150-1159. PubMed ID: 31686009
[TBL] [Abstract][Full Text] [Related]
5. Delta opioid receptor expression correlates to skin ageing and melanin expression in Asian women.
Bigliardi PL; Lo S; Bigliardi E; Dancik Y; Leblanc-Noblesse E; Bigliardi-Qi M
Exp Dermatol; 2024 Jun; 33(6):e15096. PubMed ID: 38922774
[TBL] [Abstract][Full Text] [Related]
6. Targeting endosomal receptors, a new direction for polymers in nanomedicine.
Ramirez-Garcia PD; Veldhuis NA; Bunnett NW; Davis TP
J Mater Chem B; 2023 Jun; 11(24):5390-5399. PubMed ID: 37219363
[TBL] [Abstract][Full Text] [Related]
7. Nociceptor sensitization in pain pathogenesis.
Gold MS; Gebhart GF
Nat Med; 2010 Nov; 16(11):1248-57. PubMed ID: 20948530
[TBL] [Abstract][Full Text] [Related]
8. Breaking Down the Pain Pathway: Bacterial Proteases Activate Nociceptors to Cause Pain.
Altier C
Cell Mol Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38583482
[No Abstract] [Full Text] [Related]
9. Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor.
Gillis A; Kliewer A; Kelly E; Henderson G; Christie MJ; Schulz S; Canals M
Trends Pharmacol Sci; 2020 Dec; 41(12):947-959. PubMed ID: 33097283
[TBL] [Abstract][Full Text] [Related]
10. The Life Cycle of the Mu-Opioid Receptor.
Cuitavi J; Hipólito L; Canals M
Trends Biochem Sci; 2021 Apr; 46(4):315-328. PubMed ID: 33127216
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalized GPCR Signaling from Intracellular Membranes.
Crilly SE; Puthenveedu MA
J Membr Biol; 2021 Jun; 254(3):259-271. PubMed ID: 33231722
[TBL] [Abstract][Full Text] [Related]
12. GRKs as Key Modulators of Opioid Receptor Function.
Lemel L; Lane JR; Canals M
Cells; 2020 Nov; 9(11):. PubMed ID: 33147802
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.
Møller TC; Pedersen MF; van Senten JR; Seiersen SD; Mathiesen JM; Bouvier M; Bräuner-Osborne H
Sci Rep; 2020 Oct; 10(1):17395. PubMed ID: 33060647
[TBL] [Abstract][Full Text] [Related]
14. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.
Jiménez-Vargas NN; Yu Y; Jensen DD; Bok DD; Wisdom M; Latorre R; Lopez C; Jaramillo-Polanco JO; Degro C; Guzman-Rodriguez M; Tsang Q; Snow Z; Schmidt BL; Reed DE; Lomax AE; Margolis KG; Stein C; Bunnett NW; Vanner SJ
Gut; 2022 Apr; 71(4):695-704. PubMed ID: 33785555
[TBL] [Abstract][Full Text] [Related]
15. Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases.
Mailhot B; Christin M; Tessandier N; Sotoudeh C; Bretheau F; Turmel R; Pellerin È; Wang F; Bories C; Joly-Beauparlant C; De Koninck Y; Droit A; Cicchetti F; Scherrer G; Boilard E; Sharif-Naeini R; Lacroix S
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32573694
[TBL] [Abstract][Full Text] [Related]
16. Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system.
Gottesman-Katz L; Latorre R; Vanner S; Schmidt BL; Bunnett NW
Gut; 2021 May; 70(5):970-981. PubMed ID: 33272979
[TBL] [Abstract][Full Text] [Related]
17. Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments.
Ford AC; Vanner S; Kashyap PC; Nasser Y
Gastroenterology; 2024 Jun; 166(6):976-994. PubMed ID: 38325759
[TBL] [Abstract][Full Text] [Related]
18. The Impact of UFP-512 in Mice with Osteoarthritis Pain: The Role of Hydrogen Sulfide.
Batallé G; Bai X; Balboni G; Pol O
Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136204
[TBL] [Abstract][Full Text] [Related]
19. Targeting sensory neuron GPCRs for peripheral neuropathic pain.
Uniyal A; Tiwari V; Tsukamoto T; Dong X; Guan Y; Raja SN
Trends Pharmacol Sci; 2023 Dec; 44(12):1009-1027. PubMed ID: 37977131
[TBL] [Abstract][Full Text] [Related]
20. Redox-active endosomes mediate α5β1 integrin signaling and promote chondrocyte matrix metalloproteinase production in osteoarthritis.
Miao MZ; Su QP; Cui Y; Bahnson EM; Li G; Wang M; Yang Y; Collins JA; Wu D; Gu Q; Chubinskaya S; Diekman BO; Yamada KM; Loeser RF
Sci Signal; 2023 Oct; 16(809):eadf8299. PubMed ID: 37906629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
